Spyre Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Waltham, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Spyre Therapeutics, Inc. has filed 781 SEC EDGAR filings since 24 Mar 2015

SEC filing history

Showing 276-300 of 781 matching filings.

Per page
25
Current page
12
4

4

Filing date
05 Sep 2023
Reporting date
01 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
05 Sep 2023
Reporting date
01 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
28 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-37722

PRE 14A

Filing date
08 Aug 2023
Reporting date
07 Aug 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-273769

S-3

Filing date
07 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89456

SC 13G filing

Filing date
28 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89456

SC 13G filing

Filing date
18 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89456

SC 13G

Filing date
10 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-486102

D filing

Filing date
06 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89456

ACQUISITION OF BENEFICIAL OWNERSHIP

Filing date
03 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
30 Jun 2023
Reporting date
22 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-89456

SC 13D

Filing date
30 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
30 Jun 2023
Reporting date
22 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
30 Jun 2023
Reporting date
22 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Jun 2023
Reporting date
22 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Jun 2023
Reporting date
22 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Jun 2023
Reporting date
22 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Jun 2023
Reporting date
22 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Jun 2023
Reporting date
22 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .